Trials / Conditions / Urothelial Bladder Cancer
Urothelial Bladder Cancer
6 registered clinical trials studyying Urothelial Bladder Cancer — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer NCT06335667 | University of California, Irvine | N/A |
| Recruiting | Longitudinal Bladder Cancer Study for Tumour Recurrence NCT05080998 | Pacific Edge Limited | — |
| Terminated | Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab NCT04779151 | Gustave Roussy, Cancer Campus, Grand Paris | Phase 2 |
| Recruiting | Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients Without Progression and With no M NCT04428554 | Institut Claudius Regaud | Phase 2 |
| Terminated | Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible F NCT04197986 | QED Therapeutics, a BridgeBio company | Phase 3 |
| Completed | Study of Tremelimumab in Patients With Advanced Solid Tumors NCT02527434 | AstraZeneca | Phase 2 |